GAPDHP33

Across TCGA pan-cancer cohorts, GAPDHP33 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated GAPDHP33 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher GAPDHP33 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GAPDHP33 expression acts as an unfavorable survival marker, although some lineages such as KIRP and UCS show a favorable association.

READ, LIHC, and UVM are the cancer types where GAPDHP33 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Median	II,III,IV	0.327	0.772	.002	54	view →
LIHC	OS	Median	All	0.375	0.644	<.001	52	view →
UVM	DFS	Quartile	All	0.496	0.896	<.001	50	view →
BRCA	DFS	Tertile	All	0.874	0.928	.002	35	view →
KICH	OS	Tertile	All	0.810	0.974	.007	29	view →
KIRP	DFS	Tertile	III,IV	1.000	0.252	.011	28	view →
STAD	DFS	Median	III,IV	0.190	0.554	.006	27	view →
UCS	OS	Tertile	IV	0.844	0.228	.024	24	view →
CESC	DFS	Median	All	0.755	0.877	.001	22	view →
LAML	DFS	Quartile	All	0.501	0.209	.003	20	view →
CHOL	DFS	Median	All	0.225	0.719	.001	15	view →
ACC	OS	Median	All	0.808	0.927	.015	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

GAPDHP33–READ (DFS)

Open the READ breakdown →